Effector Total Liab vs Cash Analysis
| EFTR Stock | | | USD 0.0002 0.00 0.00% |
Effector Therapeutics financial indicator trend analysis is much more than just examining Effector Therapeutics latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Effector Therapeutics is a good investment. Please check the relationship between Effector Therapeutics Total Liab and its Cash accounts. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Effector Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
To learn how to invest in Effector Stock, please use our
How to Invest in Effector Therapeutics guide.
Total Liab vs Cash
Total Liab vs Cash Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Effector Therapeutics Total Liab account and
Cash. At this time, the significance of the direction appears to have very week relationship.
The correlation between Effector Therapeutics' Total Liab and Cash is 0.28. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Cash in the same time period over historical financial statements of Effector Therapeutics, assuming nothing else is changed. The correlation between historical values of Effector Therapeutics' Total Liab and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Effector Therapeutics are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Total Liab i.e., Effector Therapeutics' Total Liab and Cash go up and down completely randomly.
Correlation Coefficient | 0.28 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.
Cash
Cash refers to the most liquid asset of Effector Therapeutics, which is listed under current asset account on Effector Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Effector Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Effector Therapeutics account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Effector Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Effector Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Effector Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in population.
To learn how to invest in Effector Stock, please use our
How to Invest in Effector Therapeutics guide.At this time, Effector Therapeutics'
Issuance Of Capital Stock is relatively stable compared to the past year. As of 12/12/2025,
Sales General And Administrative To Revenue is likely to grow to 3.47, though
Enterprise Value Over EBITDA is likely to grow to
(1.04).
Effector Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Effector Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Effector Therapeutics fundamental ratios Accounts
Additional Tools for Effector Stock Analysis
When running Effector Therapeutics' price analysis, check to
measure Effector Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Effector Therapeutics is operating at the current time. Most of Effector Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Effector Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Effector Therapeutics' price. Additionally, you may evaluate how the addition of Effector Therapeutics to your portfolios can decrease your overall portfolio volatility.